Related Experiment Video
Updated: May 21, 2026

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
Inherited calcium channelopathies in the pathophysiology of arrhythmias
Luigi Venetucci1, Marco Denegri, Carlo Napolitano
1Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri, Via Maugeri 10/10a, Pavia 27100, Italy.
Insights
Genetic mutations in cardiac calcium regulation proteins cause life-threatening arrhythmias. Understanding these calcium-handling diseases improves knowledge of heart physiology and disease mechanisms.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Genetics of Cardiac Arrhythmias
Background:
- Cardiac calcium flux is critical for heart excitability and contractility.
- Altered calcium regulation is linked to heart disease, contractile dysfunction, and arrhythmias.
- Genetic abnormalities in calcium-handling proteins are increasingly recognized as causes of inherited arrhythmias.
Purpose of the Study:
- To review the structure and function of key cardiac calcium-handling proteins.
- To elucidate mechanisms by which mutations in these proteins lead to specific clinical phenotypes.
- To provide an overview of genetic calcium-handling diseases and their impact on cardiac function.
Main Methods:
- Review of scientific literature on calcium-handling proteins and cardiac arrhythmias.
- Analysis of gene mutations in ryanodine receptor 2 (RYR2), calsequestrin 2 (CASQ2), and L-type calcium channel proteins.
- Correlation of identified mutations with clinical phenotypes such as CPVT, Timothy syndrome, Brugada syndrome, and early repolarization syndrome.
Main Results:
- Mutations in RYR2 and CASQ2 are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT).
- Defects in L-type calcium channel genes cause diverse arrhythmias, including Timothy syndrome, Brugada syndrome, and early repolarization syndrome.
- Identification of specific gene mutations clarifies the role of calcium dysregulation in cardiac disease.
Conclusions:
- Genetic mutations in cardiac calcium-handling proteins are a significant cause of inherited arrhythmias.
- Understanding these mutations provides insights into the pathophysiology of cardiac excitability and contractility.
- This knowledge advances the diagnosis and potential treatment strategies for calcium-handling diseases.
Abstract:
Regulation of calcium flux in the heart is a key process that affects cardiac excitability and contractility. Degenerative diseases, such as coronary artery disease, have long been recognized to alter the physiology of intracellular calcium regulation, leading to contractile dysfunction or arrhythmias. Since the discovery of the first gene mutation associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) in 2001, a new area of interest in this field has emerged--the genetic abnormalities of key components of the calcium regulatory system. Such anomalies cause a variety of genetic diseases characterized by the development of life-threatening arrhythmias in young individuals. In this Review, we provide an overview of the structural organization and the function of calcium-handling proteins and describe the mechanisms by which mutations determine the clinical phenotype. Firstly, we discuss mutations in the genes encoding the ryanodine receptor 2 (RYR2) and calsequestrin 2 (CASQ2). These proteins are pivotal to the regulation of calcium release from the sarcoplasmic reticulum, and mutations can cause CPVT. Secondly, we review defects in genes encoding proteins that form the voltage-dependent L-type calcium channel, which regulates calcium entry into myocytes. Mutations in these genes cause various phenotypes, including Timothy syndrome, Brugada syndrome, and early repolarization syndrome. The identification of mutations associated with 'calcium-handling diseases' has led to an improved understanding of the role of calcium in cardiac physiology.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

